Browse the corpus

Walk the evidence base by book and chapter — the raw source passages that ground Ask, Differential, and the rest.

• Comorbidities in alopecia areata: A systematic review and meta-analysis1 passage
• Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1)1 passage
• Epidemiology of alopecia areata, ophiasis, totalis, and universalis: A systematic review and meta-analysis1 passage
• Full Guidelines-From the Medical Board of the National Psoriasis Foundation: Perioperative management of systemic immunomodulatory agents in patients with psoriasis and psoriatic arthritis1 passage
• Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities1 passage
• Joint position statement from the National Psoriasis Foundation Medical Board and the International Psoriasis Council on routine testing for latent tuberculosis infection prior to and during treatment of psoriasis patients with interleukin 17 or interleukin 23 inhibitors1 passage
• North American clinical practice guidelines for the medical management of hidradenitis suppurativa in special patient populations1 passage
• Psychosocial and psychiatric comorbidities and health-related quality of life in alopecia areata: A systematic review1 passage
• Serlopitant for psoriatic pruritus: A phase 2 randomized, double-blind, placebo-controlled clinical trial1 passage
• The effectiveness of treatments for androgenetic alopecia: A systematic review and meta-analysis1 passage
• Treatment of pediatric alopecia areata: A systematic review1 passage